PODCAST

Pulmonary Medicine

ReachMD

science & medicine medicine

All Episodes

00:00:00

Assessing Quality of Care: Implementing a Lung...

Pulmonary Medicine ·

2021/04/16

Host: Jacob Sands, MD Guest: Andrea B. McKee, MD How can a lung screening program enhance the quality of care for patients with lung cancer? Dr. Andrea McKee, Chair Emeritus in Radiation Oncology and Director of the Lung Screening Program at Lahey Hospital and Medical Center, shares how she and her colleagues designed this program at Lahey Hospital and Medical Center.

00:00:00

Understanding Updates in Lung Cancer Screening

Pulmonary Medicine ·

2021/04/16

Host: Jacob Sands, MD Guest: Andrea B. McKee, MD Lung cancer screening is one of the most critical components of reducing cancer mortality rates. Dr. Andrea McKee, Chair Emeritus in Radiation Oncology and Director of the Lung Screening Program at Lahey Hospital and Medical Center, joins Dr. Jacob Sands to discuss updates in lung screening.

00:00:00

Exploring Early-Stage Mesothelioma: What Are the...

Pulmonary Medicine ·

2021/04/01

Host: Jacob Sands, MD Guest: Aaron S. Mansfield, MD There are different treatment options available for early-stage mesothelioma, and there seem to be differences in standard practice from one center to the next. Joining Dr. Jacob Sands to share how he approaches the treatment of early-stage mesothelioma using the latest options is Dr. Aaron Mansfield, an Associate Professor of Oncology and Co-Director of Precision Cancer Therapeutics at Mayo Clinic in Rochester.

00:00:00

Expanding on the Neurologic Effects of COVID-19

Pulmonary Medicine ·

2021/03/26

Host: Andrew Wilner, MD, FACP, FAAN Guest: Jennifer A. Frontera, MD Although the impact of COVID-19 can be long-lasting, many have had similar effects, even if they aren’t diagnosed with the disease. Dr. Jennifer Frontera, a neurocritical care specialist and professor of neurology at the NYU Grossman School of Medicine, shares some insight on the neurological symptoms that patients with COVID-19 are facing.

00:00:00

A Step-by-Step Approach to Managing Mesothelioma

Pulmonary Medicine ·

2021/03/24

Host: Jacob Sands, MD Guest: Aaron S. Mansfield, MD Mesothelioma is a cancer with limited treatment options, so how can we manage it in the first and second-line settings and beyond? Here with Dr. Jacob Sands to walk us through the various treatment approaches to mesothelioma is Dr. Aaron Mansfield, Associate Professor of Oncology and Co-Director of Precision Cancer Therapeutics at Mayo Clinic in Rochester.

00:00:00

Examining Genomic Testing & Targeted Therapies in...

Pulmonary Medicine ·

2021/03/02

Host: Jacob Sands, MD Guest: Benjamin Levy, MD What is genomic testing, and how has this advancement become such an important part of lung cancer treatment? Dr. Jacob Sands is joined Dr. Ben Levy, an associate professor of oncology at the Johns Hopkins University School of Medicine to discuss targeted therapies and testing strategies in patients with lung cancer.

00:00:00

An Oncologist's View: Cancer Care & Self Care During...

Pulmonary Medicine ·

2021/01/22

Host: Jacob Sands, MD Cancer care has evolved since the initial outbreak of the COVID-19 pandemic. What do we need to know about caring for our cancer patients during this winter season? Dr. Jacob Sands, Thoracic Medical Oncologist at the Dana-Farber Institute in Boston shares what cancer patients can do to take care of themselves during the winter season.

00:00:00

Assessing Advancements in Treatment Options for Small...

Pulmonary Medicine ·

2021/01/06

Host: Jacob Sands, MD Guest: Taofeek K. Owonikoko, MD, PhD, MSCR After years without new approvals, advancements in small cell lung cancer are at the forefront of oncology. But what do these therapeutic developments mean for the field? Dr. Taofeek Owonikoko, professor and vice-chair for faculty development in the Department of Hematology and Medical Oncology at Emory University School of Medicine, joins Dr. Jacob Sands to talk about long-awaited developments in small cell lung

00:00:00

Another COVID-19 Vaccine Milestone Reached

Pulmonary Medicine ·

2020/12/29

Host: Linda Bernstein, Pharm.D. The U.S. Food and Drug Administration issued an emergency use authorization, or EUA, for the Moderna COVID-19 vaccine. The second vaccination to achieve EUA designation, the Moderna vaccine will be distributed throughout the US for patients 18 years and older. In this episode of The Drug Report, Dr. Linda Bernstein discusses this newly-approved vaccine and how it compares to others. Published December 29, 2020

00:00:00

FDA Issues EUA for Pfizer-BioNTech COVID-19 Vaccine

Pulmonary Medicine ·

2020/12/18

Host: Linda Bernstein, Pharm.D. The first vaccine to receive Emergency Use Authorization from the US Food and Drug Administration, this authorization allows the Pfizer-BioNTech COVID-19 vaccine to be distributed throughout the US. But what do we know about this vaccine? In this episode of The Drug Report, Dr. Linda Bernstein discusses the Pfizer-BioNTech COVID-19 vaccine. Published December 18, 2020

00:00:00

The FDA Expands Indication for Baloxavir Marboxil to...

Pulmonary Medicine ·

2020/12/02

Host: Linda Bernstein, Pharm.D. To prevent the flu from spreading concurrently with COVID-19, The U.S. Food and Drug Administration has expanded the approved indication for baloxavir marboxil to include post-exposure prevention of influenza. On this episode of The Drug Report, Dr. Linda Bernstein dives into this oral anti-influenza drug. Published December 2, 2020

00:00:00

A Look into the Development of a COVID-19 Vaccine

Pulmonary Medicine ·

2020/11/30

Host: Linda Bernstein, Pharm.D. Pfizer and BioNTech recently announced that their mRNA vaccine for the COVID-19 virus was 90 percent effective, and the companies plan to apply for Emergency Use Authorization. This episode of The Drug Report dives into this vaccine’s Phase 3 clinical trial and explores developments made by other companies in the search for a COVID-19 vaccine. Published November 30, 2020

00:00:00

Exploring the Emergency Use Authorization for a...

Pulmonary Medicine ·

2020/11/30

Host: Linda Bernstein, Pharm.D. This episode of The Drug Report takes a look at a COVID-19 cocktail comprised of the coadministration of casirivimab and imdevimab, which has proven to decrease hospitalization and emergency room visits. Published November 30, 2020

00:00:00

Monoclonal Antibody Treatment for COVID-19 Receives...

Pulmonary Medicine ·

2020/11/30

Host: Linda Bernstein, Pharm.D. The U.S. Food and Drug Administration has granted Eli Lilly and Company’s trial vaccine for COVID-19 an Emergency Use Authorization, or EUA. On this episode of The Drug Report, learn more about this monoclonal antibody and how the company plans on distributing it. Published November 30, 2020

00:00:00

Measles Vaccination Rates Drop—But Pharmacists Can Help

Pulmonary Medicine ·

2020/11/30

Host: Linda Bernstein, Pharm.D. With the spread of the COVID-19 pandemic, fewer children have received a measles vaccination, and progress towards eliminating this disease has halted. How can pharmacists encourage more pediatric measles vaccinations? In this episode of The Drug Report, Dr. Linda Bernstein takes a look at the vast number of children globally who’ve yet to receive this vaccine. Published November 30, 2020

00:00:00

CDC Playbook for COVID-19 Vaccine Distribution

Pulmonary Medicine ·

2020/11/17

Host: Linda Bernstein, Pharm.D. In light of the COVID-19 pandemic, the Centers for Disease Control and Prevention, or the CDC, plans to use pharmacies to increase access to the COVID-19 vaccine when it is ready for distribution. In this episode of The Drug Report, Linda Bernstein will explain the CDC’s recently-developed Vaccination Program Interim Playbook. Published November 17, 2020

00:00:00

FDA Approves Remdesivir, the First COVID-19 Treatment

Pulmonary Medicine ·

2020/11/06

Host: Linda Bernstein, Pharm.D. The Food and Drug Administration announced that Remdesivir is the first treatment for COVID-19 to receive their approval. To help us better understand this antiviral agent, Dr. Linda Bernstein discusses emerging studies uncovering the benefits and limitations of Remdesivir. Published November 6, 2020

00:00:00

Inside the COVID-19 Field Hospital in Baltimore’s...

Pulmonary Medicine ·

2020/05/26

Host: Joshua Sharfstein, MD Host: Stephanie Desmon Guest: James Robert Ficke, M.D. The Joint Hopkins Maryland Federal Medical Station, a 250-bed unit inside Baltimore’s convention center, opened on April 27 for non-critical patients recovering from COVID-19. Dr. James Ficke, the Station’s Director, talks with Stephanie Desmon about how his experience standing up combat hospitals in northern Iraq prepared him, the influx of patients they’re seeing, and what it takes to set up a

00:00:00

Where Are We Now? New Findings About COVID-19 & How...

Pulmonary Medicine ·

2020/05/26

Host: Joshua Sharfstein, MD Host: Stephanie Desmon Guest: Albert Wu, MD It’s been a few months since COVID-19 first arrived in the US, so what have we learned? Dr. Albert Wu returns to the podcast with Stephanie Desmon to discuss social distancing fatigue, new symptoms and disease observations, hopes for treatment, and what we should expect in the coming months in terms of a “return to normal.” Published May 13, 2020

00:00:00

How COVID-19 May Cause Increases in Maternal & Child...

Pulmonary Medicine ·

2020/05/14

Host: Joshua Sharfstein, MD Host: Sara Bennett, PhD Guest: Timothy J. Roberton, DrPH The global health community has worked for years to lower rates of maternal and child mortality in low- and middle-income countries. But while the world focuses on the number of deaths from COVID-19, estimates of indirect mortality due to disruptions in health systems cannot be ignored. Tim Roberton, an assistant scientist in international health, talks with guest host Sara Bennett, a professor

242 results

Pulmonary Medicine

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事